Evidence map›Paper›PMID 21044009›Full record

ReviewCurrent pharmaceutical biotechnology2011

Infection, stem cells and cancer signals.

S Sell

Abstract readReview
In one paragraph

Review in Current pharmaceutical biotechnology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Food and waterborne parasitology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. DNA damage in inflammation-related carcinogenesis and cancer stem cells.Oxidative medicine and cellular longevity · 2013
    Review
  8. Shifting the paradigm in radiation safety.Dose-response : a publication of International Hormesis Society · 2012
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

S SellWadsworth Center and Ordway Research Institute, Empire State Plaza, Albany, NY 12201, USA. ssell@wadsworth.org
Wadsworth Center · US

Funding

STEM CELLS AND HEPATOCARCINOGENESISR01CA112481 · NCI · ORDWAY RESEARCH INSTITUTE, INC. · PI SELL, STEWART · 2005 to 2009
$1.3M
NCI NIH HHS R01 CA112481
6 · The paper itself

Abstract

The association of cancer with preceding parasitic infections has been observed for over 200 years. Some such cancers arise from infection of tissue stem cells by viruses with insertion of viral oncogenes into the host DNA (mouse polyoma virus, mouse mammary tumor virus). In other cases the virus does not insert its DNA into the host cells, but rather commandeers the metabolism of the infected cells, so that the cells continue to proliferate and do not differentiate (human papilloma virus and cervical cancer). Cytoplasmic Epstein Barr virus infection is associated with a specific gene translocation (Ig/c-myc) that activates proliferation of affected cells (Burkitt lymphoma). In chronic osteomyelitis an inflammatory reaction to the infection appears to act through production of inflammatory cytokines and oxygen radical formation to induce epithelial cancers. Infection with Helicobacter pylori leads to epigenetic changes in methylation and infection by a parasite. Clonorchis sinensis also acts as a promoter of cancer of the bile ducts of the liver (cholaniocarcinoma). The common thread among these diverse pathways is that the infections act to alter tissue stem cell signaling with continued proliferation of tumor transit amplifying cells.

Indexed as

Stem CellsAnimalsBacterial InfectionsCell ProliferationDNA MethylationFemaleHumansMaleMiceMutationNeoplasmsNeoplastic Stem CellsSignal TransductionTrematode InfectionsVirus DiseasesViruses

Identifiers

PMID21044009
PMCPMC3611662
OpenAlexW2029679349

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.